You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

CLINICAL TRIALS PROFILE FOR ARIPIPRAZOLE LAUROXIL

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for ARIPIPRAZOLE LAUROXIL

Subscribe to access the full database, or Sign Up
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT01469039 ↗	A Study to Evaluate the Efficacy and Safety of ALKS 9072 (Also Known as Aripiprazole Lauroxil, ALKS 9070, or ARISTADA) in Subjects With Schizophrenia	Completed	Alkermes, Inc.	Phase 3	2011-12-01	The study will determine the efficacy of ALKS 9072 (also known as aripiprazole lauroxil or ALKS 9070) for the treatment of schizophrenia in subjects experiencing an acute exacerbation.
NCT02320032 ↗	An Open-Label Study of Aripiprazole Lauroxil in Subjects With Stable Schizophrenia	Completed	Alkermes, Inc.	Phase 1	2014-12-01	This study will evaluate the safety, tolerability, and pharmacokinetics (PK) of various doses and dosing intervals of aripiprazole lauroxil.
NCT02634320 ↗	A Study of Aripiprazole Lauroxil (Also Known as ARISTADA TM) in Subjects With Schizophrenia	Completed	Alkermes, Inc.	Phase 4	2015-12-01	This study will evaluate the safety and tolerability of aripiprazole lauroxil (also known as ARISTADA, ALKS 9070).
NCT02636842 ↗	A Study of Aripiprazole Lauroxil in Subjects With Schizophrenia or Schizoaffective Disorder	Completed	Alkermes, Inc.	Phase 1	2015-12-01	The study will determine the safety, tolerability, and pharmacokinetics of aripiprazole lauroxil in adults with schizophrenia or schizoaffective disorder.
NCT03345979 ↗	A Study of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia	Completed	Alkermes, Inc.	Phase 3	2017-11-15	This study will evaluate the efficacy of initiating treatment of schizophrenia with ARISTADA INITIO plus 30 mg oral aripiprazole followed by a 2-month dose of AL.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for ARIPIPRAZOLE LAUROXIL

Condition Name

Chart
Table

Condition Name for ARIPIPRAZOLE LAUROXIL
Intervention	Trials
Schizophrenia	7
Schizoaffective Disorder	1
Schizoaffective Disorder, Depressive Type	1
Schizophreniform Disorder	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for ARIPIPRAZOLE LAUROXIL
Intervention	Trials
Schizophrenia	7
Disease	2
Psychotic Disorders	2
Depressive Disorder	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for ARIPIPRAZOLE LAUROXIL

Trials by Country

Map
Table

Trials by Country for ARIPIPRAZOLE LAUROXIL
Location	Trials
United States	46
Russian Federation	5
Romania	2
Philippines	2
Ukraine	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for ARIPIPRAZOLE LAUROXIL
Location	Trials
California	6
Texas	5
Illinois	5
Missouri	4
Florida	4
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for ARIPIPRAZOLE LAUROXIL

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for ARIPIPRAZOLE LAUROXIL
Clinical Trial Phase	Trials
Phase 4	3
Phase 3	2
Phase 1	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for ARIPIPRAZOLE LAUROXIL
Clinical Trial Phase	Trials
Completed	5
Not yet recruiting	1
Recruiting	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for ARIPIPRAZOLE LAUROXIL

Sponsor Name

Chart
Table

Sponsor Name for ARIPIPRAZOLE LAUROXIL
Sponsor	Trials
Alkermes, Inc.	7
University of California, Los Angeles	1
University of Miami	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for ARIPIPRAZOLE LAUROXIL
Sponsor	Trials
Industry	7
Other	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.